Merz Pharmaceuticals, LLC et al v. Suven Life Sciences, Ltd. et al
Merz Pharmaceuticals, LLC and Merz North America, Inc. |
Suven Life Sciences, Ltd., Taro Pharmaceuticals U.S.A., Inc. and Taro Pharmaceutical Industries Ltd. |
5:2018cv00584 |
December 12, 2018 |
US District Court for the Eastern District of North Carolina |
Terrence W Boyle |
Patent |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on January 18, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 8 Waiver of Service Returned Executed filed by Merz Pharmaceuticals, LLC, Merz North America, Inc.. Taro Pharmaceutical Industries Ltd. waiver sent on 1/4/2019, answer due 3/5/2019. (Morris, Robert) |
Filing 7 Waiver of Service Returned Executed filed by Merz Pharmaceuticals, LLC, Merz North America, Inc.. Suven Life Sciences, Ltd. waiver sent on 1/4/2019, answer due 3/5/2019. (Morris, Robert) |
Filing 6 Summons Issued as to Suven Life Sciences, Ltd., Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (*NOTICE: Counsel shall print the attached summons and serve with other case opening documents in accordance with Fed.R.Civ.P. 4.*) (Stouch, L.) |
Filing 5 PATENT REPORT: Copy of report and complaint forwarded to Mail Stop 8, Director of the U.S. Patent and Trademark Office, P.O. Box 1450 Alexandria, VA 22313-1450 via US Mail on December 13, 2018. (Rudd, D.) |
Filing 4 Notice of Appearance filed by Robert J. Morris on behalf of Merz North America, Inc., Merz Pharmaceuticals, LLC. (Morris, Robert) |
Filing 3 Financial Disclosure Statement by Merz North America, Inc. identifying Corporate Parent Merz Pharma GmbH & Co. KGaA, Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz, Incorporated for Merz North America, Inc.. (Morris, Robert) |
Filing 2 Financial Disclosure Statement by Merz Pharmaceuticals, LLC identifying Corporate Parent Merz Pharma GmbH & Co. KGaA, Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz, Incorporated for Merz Pharmaceuticals, LLC. (Morris, Robert) |
Filing 1 COMPLAINT against Suven Life Sciences, Ltd., Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. ( Filing fee $ 400 receipt number 0417-4757579.), filed by Merz Pharmaceuticals, LLC, Merz North America, Inc.. (Attachments: #1 Exhibit US Patent No. 7,638,552, #2 Exhibit US Patent No. 7,816,396, #3 Civil Cover Sheet Civil Cover Sheet, #4 Proposed Summons Proposed Summons - Suven, #5 Proposed Summons Proposed Summons - Taro Pharmaceutical Industries, #6 Proposed Summons Proposed Summons - Taro Pharmaceuticals U.S.A.) (Morris, Robert) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.